-
Awarded13/08/2026
-
Today17/09/2026
Utilities
- indicates text translated automatically in your browsing language
High Load Influenza Vaccine
Successive supply of reinforced inactivated influenza vaccines (EFLUELDA) produced from viruses grown in embryonic eggs, fractional viruses or surface antigens (H and N), or similar, of 60 micrograms of binder in each strain for administration to persons aged 65 years and over, institutionalized persons in nursing homes aged 60 years and over and immunosuppressed persons aged 60 years and over.
Type: price
Description: Oferta económica
Weight (percentage, exact): 60
Criterion:
Type: price
Description: Dosis sin cargo
Weight (percentage, exact): 10
Criterion:
Type: quality
Description: Actividades de mejora de las coberturas vacunales
Weight (percentage, exact): 20
Criterion:
Type: quality
Description: Mejora en función de resultados en salud
Weight (percentage, exact): 10
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.